Bone Biologics share price logo

Bone Biologics

NASDAQ: BBLG

$0.60

-0.04

(-5.50%)

as on

Bone Biologics Stock Performance

as on August 21, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $0.60
    $0.63
    downward going graph

    0.83%

    Downside

    4.13%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.62
    $4.13
    downward going graph

    -2.48%

    Downside

    582.63%

    Upside

    downward going graph

Bone Biologics share price movements today

Previous Close
$0.64
Open
$0.62
Volume
670.3K
Market Cap
$1.2M
Day's Low - High
$0.60 - $0.63
52 Week Low - High
$0.62 - $4.13

Bone Biologics Historical Returns

1 Month Return
-44.02 %
3 Month Return
-48.43 %
1 Year Return
-70.23 %
3 Year Return
-98.61 %
5 Year Return
0 %

Bone Biologics Stock Fundamentals & Key Indicators

Check Bone Biologics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.2M

EPS (TTM)

-2.76

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.24

Industry PE ratio

-1.5966015625

PEG Ratio

-0.03142832728713359

EBITDA

-2.1M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-50.45%

Bone Biologics Stock Valuation

Track how Bone Biologics P/E has moved over time to understand its valuation trends.

Bone Biologics in the last 5 years

  • Overview

  • Trends

Lowest (-67.73x)

December 31, 2021

Industry (-1.60x)

December 31, 2025

Today (-0.55x)

December 31, 2025

Highest (-0.55x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.55x

Bone Biologics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bone Biologics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$1.2MNA-0.240.00%NA
BUY$43.7B669.3%NA0.00%NA
BUY$128.2B154.86%29.8286.04%NA
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for Bone Biologics Stock including INR - Dollar returns

The Bone Biologics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Bone Biologics investment value today

Current value as on today

₹30,242

Returns

-₹69,758

(-69.76%)

Returns from Bone Biologics Stock

-₹72,500 (-72.5%)

Dollar Impact

₹2,742 (+2.74%)

Analyst Recommendation on Bone Biologics Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Bone Biologics. Average target price of $12.2

Bone Biologics Share Price Target

Get share price movements and forecasts by analysts on Bone Biologics.

What analysts predicted

95.04%UPSIDE

Target Price

$12.2

Current Price

$0.605

Analyzed by

7 Analysts

Target

$12.20

Bone Biologics target price $12.2, a slight upside of 95.04% compared to current price of $0.605. According to 7 analysts rating.

Indian Investors' Interest in Bone Biologics Stock

Search interest for Bone Biologics Stock has decreased by -51% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-51% versus previous 30 day period

Bone Biologics Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-1
0
0
0
-1
-1
0
0
0
0
EBITDA
0
0
0
0
-1
-1
0
0
0
0
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
-
-
-
-
-
-
0
-
-
Income Before Tax
-1
0
0
0
-1
-1
0
0
0
0
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-1
0
0
0
-1
-1
0
0
0
0
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Bone Biologics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
-
-
-
-
-
-
Operating Income
-2
-2
-2
0
-1
-3
-9
-4
-3
EBITDA
-2
-2
-2
0
0
0
0
0
-3
Interest Expense
4
1
0
0
0
0
-
-
-
Depreciation
0
0
0
-
-
-
9
4
-
Income Before Tax
-7
-4
-3
-1
-1
-1
-8
-4
-3
Income Tax Expense
0
0
0
0
-
-
-
-
-
Net Income
-7
-4
-3
-1
-1
-1
-8
-4
-3
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Bone Biologics Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-1
0
0
0
-1
-1
0
0
0
0
Operating Cash Flow
-2
-1
0
0
-1
0
0
0
0
0
Investing Cash Flow
-
-
-
-
-
-
-
-
-
-
Financing Cash Flow
0
1
0
1
1
0
4
-
-
-
Change in Cash
-1
0
0
1
0
0
3
0
0
0

Bone Biologics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-7
-4
-3
-1
-1
-1
-8
-4
-3
Operating Cash Flow
-3
-4
-3
0
-1
-3
-9
-4
-2
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
3
4
2
0
7
4
5
4
4
Change in Cash
0
0
0
0
6
0
-4
0
2

Mutual Funds that own Bone Biologics Stock

Check out the Mutual Funds with significant holdings in Bone Biologics.

Funds
Holdings
Shares Held
Fidelity Concord Street Trust
0.434604%
7868

Global Institutional Holdings in Bone Biologics

Funds
Holdings
Bank of America Corp
0%
HRT FINANCIAL LLC
0%
Clear Street Group Inc
0%
Citadel Advisors Llc
0%
CLEAR STREET LLC.
0.01%

Insights on Bone Biologics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 493.6% return, outperforming this stock by 564.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 624.7% return, outperforming this stock by 722.9%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, BBLG stock has moved down by -42.8%

About Bone Biologics

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine implants, non-union trauma cases, and osteoporosis applications. It serves spine surgeons and patients with a skeletal bone defect or bone-related condition in their spine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion by local administration, osteoporosis, and trauma applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
OrganisationBone Biologics
Headquarters2 Burlington Woods Drive, Burlington, MA, United States, 01803
IndustryBiotechnology
CEOMr. Jeffrey Frelick
E-voting on sharesClick here to vote

Key Management of Bone Biologics

Name

Title

Mr. Jeffrey Frelick

CEO & President

Ms. Deina H. Walsh CPA

Chief Financial Officer

FAQs

What is Bone Biologics share price today?

Bone Biologics share price today is $0.61 as on at the close of the market. Bone Biologics share today touched a day high of $0.63 and a low of $0.60.

What is the 52 week high and 52 week low for Bone Biologics share?

Bone Biologics share touched a 52 week high of $4.13 on and a 52 week low of $0.62 on . Bone Biologics stock price today i.e. is closed at $0.61,which is 85.35% down from its 52 week high and -2.42% up from its 52 week low.

What is Bone Biologics's market capitalisation today?

Bone Biologics market capitalisation is $0.00T as on .

How to invest in Bone Biologics Stock (BBLG) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bone Biologics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bone Biologics Shares that will get you 2.4793 shares as per Bone Biologics share price of $0.61 per share as on August 21, 2026 at 1:29 am IST.

What is the minimum amount required to buy Bone Biologics Stock (BBLG) from India?

Indian investors can start investing in Bone Biologics (BBLG) shares with as little as ₹95.695 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.95 in Bone Biologics stock (as per the Rupee-Dollar exchange rate as on ). Based on Bone Biologics share’s latest price of $0.61 as on August 21, 2026 at 1:29 am IST, you will get 16.5289 shares of Bone Biologics. Learn more about fractional shares .